NASDAQ Pharma Gains - Peregrine Pharmaceuti
Post# of 29735
NASDAQ Pharma Gains - Peregrine Pharmaceuticals, Inc., DARA BioSciences, Inc., and Pacira Pharmaceuticals, Inc. Added to Growing Stock Report's NASDAQ Pharma Watch List.
New York, NY -- ( SBWIRE ) -- 02/02/2013 -- NASDAQ Pharma Gainers: Growing Stock Report adds Peregrine Pharmaceuticals, Inc., DARA BioSciences, Inc., and Pacira Pharmaceuticals, Inc. to their NASDAQ Gainer Watch List.
Peregrine Pharmaceuticals, Inc. (NASDAQ
PHM) a biopharmaceutical company that engages in the research and development of monoclonal antibodies for the treatment and diagnosis of cancer and viral infections is active today as shares of the company surged earlier this month after reporting an update on an internal review of its Phase II second-line non-small cell lung cancer trial, the stock closed up (+13.30%) today with 4,199,897 shares traded. Peregrine Pharmaceuticals, Inc. (NASDAQ PHM) is currently up (+443.59%) from its 52 week low, which has prompted Growing Stock Report to add them to their NASDAQ Pharma Percentage Gainer Watch List.
Click Here to See What Other Investors are Saying About Peregrine Pharmaceuticals, Inc.
DARA BioSciences, Inc (NASDAQ
ARA) a development stage biopharmaceutical company that engages in the development and commercialization of oncology treatment and supportive care pharmaceutical products in the United Sates closed up (+8.57%) with 2,467,129 shares traded. DARA BioSciences, Inc (NASDAQ ARA) is up (+85.48%) from its 52-week low, which has prompted Growing Stock Report to add them to their NASDAQ Pharma Percentage Gainer Watch List.
Click Here to See What Other Investors are Saying About DARA BioSciences, Inc.
Pacira Pharmaceuticals, Inc. (NASDAQ CRX) a specialty pharmaceutical company that develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers closed up (+7.22%) and is currently up (+120.52%) from its 52-week low. From a technical perspective, PCRX is soaring higher here right above some near-term support at $18.50 with above-average volume. This move has started to push shares of PCRX into new 52-week-high territory and new all-time high territory, which is bullish technical price action. Whenever a stock hits new all-time highs, then it means there’s no more overhead resistance to contend with
Click Here to See What Other Investors are Saying About Pacira Pharmaceuticals, Inc.
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Contact Info:
Growing Stock Report
editor@GrowingStockReport.com
SBWire ( http://s.tt/1zhZt ) 
(0)
(0)NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.
I was born with it, I'm truly blessed!
Alway's searching for winners'
